Léa Nadège Bonkian Selected Research

1,12- bis(4- methyl- 5- (2- hydroxyethyl)thiazol- 3- ium- 3- yl)dodecane

1/2017

Safety and efficacy of the choline analogue SAR97276 for malaria treatment: results of two phase 2, open-label, multicenter trials in African patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Léa Nadège Bonkian Research Topics

Disease

3	Malaria 01/2020 - 01/2017
1	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2020

Drug/Important Bio-Agent (IBA)

2	artemisinin (artemisinine)IBA 01/2020 - 01/2018
1	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 01/2020
1	Amodiaquine (Camoquin)FDA Link 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	ArtesunateIBA 01/2020
1	1,12- bis(4- methyl- 5- (2- hydroxyethyl)thiazol- 3- ium- 3- yl)dodecaneIBA 01/2017
1	Choline (Choline Chloride)IBA 01/2017

Therapy/Procedure

3	Therapeutics 01/2020 - 01/2017
1	Chemoprevention 01/2020
1	Mass Drug Administration 01/2020